Provided is an adipose tissue transport preservation solution. Specifically, the transport preservation solution includes: (a) 60-90 parts by weight of DMEM, high glucose and phenol red-free; (b) 10-30 parts by weight of DMEM/F-12, HEPES and phenol red-free; (c) 50-200 ng/mL of a bactericide; and (d) 2-10 mmol/L of L-glutamine. Adipose tissue can be transported and preserved by the preservation solution at a low temperature of 2-8 C. for 72 h or more.

Provided is an adipose tissue transport preservation solution. Specifically, the transport preservation solution includes: (a) 60-90 parts by weight of DMEM, high glucose and phenol red-free; (b) 10-30 parts by weight of DMEM/F-12, HEPES and phenol red-free; (c) 50-200 ng/mL of a bactericide; and (d) 2-10 mmol/L of L-glutamine. Adipose tissue can be transported and preserved by the preservation solution at a low temperature of 2-8 C. for 72 h or more.

A semen stabilization medium is described, which includes pH buffer agents, inorganic salts, organic compounds, and amino acids with antioxidant properties. The stabilization medium preserves semen viability for up to 72 hours when the semen is mixed with the stabilization medium and maintained at a temperature within a 20% tolerance of human body temperature.

An alcohol-free lotion for the topical application having antiseptic properties is made by combining an aqueous phase comprising formaldehyde and at least one humectant with an oil phase comprising at least one surfactant and at least one oil; wherein the at least one humectant is present in the aqueous phase in the range of from 30 to 75 wt. %., wherein formaldehyde is present in the aqueous phase in the range of from about 1.0 to 20.0 wt. %; wherein the surfactant is present in the oil phase in the range of from about 30 to 60 wt. %; wherein the aqueous phase to oil phase ratio is from about 10:1 to 4:1; and wherein the lotion free of the odor of formaldehyde.

Provided are systems and methods for treating a biological fluid, e.g., to inactivate pathogens.

Provided are systems and methods for treating a biological fluid, e.g., to inactivate pathogens.

Embodiments of the present invention relate generally to processes, systems, and compositions useful in manipulating a ratio of viable X chromosome bearing sperm to viable Y chromosome bearing sperm in at least one sperm population and useful for preserving the resulting manipulated sperm population. In some embodiments a cryoprotectant may be incorporated into various medias used in manipulating the sperm sample, such as in a staining media, a sheath fluid, and a collection media.

Embodiments of the present invention relate generally to processes, systems, and compositions useful in manipulating a ratio of viable X chromosome bearing sperm to viable Y chromosome bearing sperm in at least one sperm population and useful for preserving the resulting manipulated sperm population. In some embodiments a cryoprotectant may be incorporated into various medias used in manipulating the sperm sample, such as in a staining media, a sheath fluid, and a collection media.

A method for preserving a tissue graft includes submerging the tissue graft in a solution containing one or more antimicrobial and/or stabilizing agents and storing the tissue graft in the solution for a period of time of at least 24 hours while the solution is in an unfrozen state. A tissue preservation system includes a solution containing one or more antimicrobial and/or stabilizing agents and a tissue graft in the solution.

A method for preserving a tissue graft includes submerging the tissue graft in a solution containing one or more antimicrobial and/or stabilizing agents and storing the tissue graft in the solution for a period of time of at least 24 hours while the solution is in an unfrozen state. A tissue preservation system includes a solution containing one or more antimicrobial and/or stabilizing agents and a tissue graft in the solution.